Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Tables)

v3.8.0.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of fair value of options granted
    December 31,   December 31,
    2017   2016
Expected life (in years)   6.5 years   6.5 years
Risk-free interest rate   1.86% – 2.00%   1.13% - 1.24%
Volatility   37%   37%
Dividend yield   0%   0%
Schedule of stock option activity
     Shares    

Weighted

Average

Exercise

 Price

   

Weighted

Average

Remaining

Contractual

 Life (Years)

   

 Intrinsic

Value

 
Outstanding at December 31, 2016     1,857,012       4.28                  
2017 Grants     1,260,000       1.96                  
Exercised     —       —                  
Cancelled, expired or forfeited     (801,977 )     3.14                  
Outstanding at December 31, 2017     2,315,035       3.41       7.25     $ 497,700  
Exercisable at December 31, 2017     890,384       4.84       4.67       —  
Schedule of non-vested stock options
     Shares    

Weighted

Average

Grant Date

Fair Value

 
Non-vested shares at December 31, 2016     1,180,030     $ 1.56  
Granted     1,260,000       0.79  
Vested     (245,402 )     1.76  
Forfeited     (769,977 )     1.28  
Non-vested shares at December 31, 2017     1,424,651     $ 0.99  
Schedule of restricted stock awards and changes
    Shares     Weighted Average
Grant Date Fair 
Value
 
             
Non-vested at December 31, 2016     716,250     $ 2.73  
Granted     710,000       1.83  
Vested     (181,750 )     2.01  
Cancelled, expired or forfeited     (259,500 )     2.56  
Non-vested at December 31, 2017     985,000     $ 2.26